Frederik De Vos

Senior Director - Quality Operations Advanced Therapies Platform Operations Johnson & Johnson

Seminars

Thursday 26th February 2026
Panel Discussion: Manufacturing Leaner & More Affordably to Accelerate Cell Therapy Development in Europe
1:30 pm
  • Identify key cost drivers in cell therapy manufacturing and discuss practical strategies to reduce them without compromising quality
  • Debate approaches to efficient scale-out and scale-up that enable broader patient access while meeting regulatory and quality standards
Frederik de Vos